Unknown

Dataset Information

0

MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells.


ABSTRACT:

Background

MicroRNAs (miRNAs) are increasingly being recognized as being involved in cancer development and progression in gliomas.

Methods

Using a model cell system developed in our lab to study glioma progression comprising human neuroglial culture (HNGC)-1 and HNGC-2 cells, we report here that miR-145 is one of the miRNAs significantly downregulated during malignant transformation in glioblastoma multiforme (GBM). In a study using tumor samples derived from various glioma grades, we show that expression of miR-145 is decreased in a graded manner, with GBM patients showing lowest expression relative to lower-grade gliomas (P < .05) and normal brain tissues (P < .0001). Functional studies involving ectopic expression of miR-145 in glioma cells had a negative impact on cell proliferation and tumor development, as well as invasion and induced apoptosis, providing further support to the concept that inactivation of miR-145 is important for glioma disease pathogenesis. More notably, these growth-suppressive effects of miR-145 are mediated through its target proteins Sox9 and the cell adhesion-associated molecule adducin 3 (ADD3).

Results

Inhibiting Sox9 and ADD3 rescued effects of miR-145 loss. Interestingly, miR-145 loss in glioma cells led to overexpression of molecules involved in cell proliferation, like cyclin D1, c-myc, and N-myc, as well as enhanced expression of cell adhesion- and invasion-related molecules N-cadherin and E-cadherin, an effect which was again restored upon miR-145 overexpression in glioma cells. The miR-145 promoter was methylated at its cytosine-phosphate-guanine (CpG) islands in the glioma cell lines studied.

Conclusion

Our study demonstrates that miR-145 has a tumor-suppressive function in glioblastoma in that it reduces proliferation, adhesion, and invasion of glioblastoma cells, apparently by suppressing the activity of oncogenic proteins Sox9 and ADD3. Reduced levels of miR-145 may lead to neoplastic transformation and malignant progression in glioma due to unregulated activity of these proteins.

SUBMITTER: Rani SB 

PROVIDER: S-EPMC3779040 | biostudies-literature | 2013 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells.

Rani Sandhya B SB   Rathod Sachin Shivaji SS   Karthik Shanmuganandam S   Kaur Navjot N   Muzumdar Dattatraya D   Shiras Anjali S AS  

Neuro-oncology 20130628 10


<h4>Background</h4>MicroRNAs (miRNAs) are increasingly being recognized as being involved in cancer development and progression in gliomas.<h4>Methods</h4>Using a model cell system developed in our lab to study glioma progression comprising human neuroglial culture (HNGC)-1 and HNGC-2 cells, we report here that miR-145 is one of the miRNAs significantly downregulated during malignant transformation in glioblastoma multiforme (GBM). In a study using tumor samples derived from various glioma grade  ...[more]

Similar Datasets

| S-EPMC7007780 | biostudies-literature
| S-EPMC5528701 | biostudies-other
| S-EPMC5604218 | biostudies-literature
| S-EPMC4409880 | biostudies-literature
| S-EPMC8415843 | biostudies-literature
| S-EPMC7072756 | biostudies-literature
| S-EPMC7415399 | biostudies-literature
| S-EPMC3140487 | biostudies-literature
| S-EPMC6594810 | biostudies-literature
| S-EPMC4922263 | biostudies-literature